Zobrazeno 1 - 10
of 31
pro vyhledávání: '"N. V. Khabarova"'
Autor:
A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 1, Pp 35-45 (2024)
Aim. To study the effect of various therapy regimens with enhanced external counterpulsation (EECP) on exercise tolerance, quality of life, indices of structural and functional state of cardiovascular system in patients with stable coronary artery di
Externí odkaz:
https://doaj.org/article/0574207cbf8f4bf0b28811f2b32a00a1
Autor:
F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, D. A. Yatsenko, А. V. Emelianov, A. S. Lishuta, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 408-413 (2021)
Aim. To study the level of serum biomarkers of endothelial dysfunction and myocardial stress in patients with various types of hypertrophic cardiomyopathy (HCM).Material and Methods. 48 patients with hypertrophic cardiomyopathy (27 men and 21 women)
Externí odkaz:
https://doaj.org/article/ba9f82e067fd4a27bdea76adb8b2bd79
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 6, Pp 892-899 (2020)
The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes) in Russia and in the world continues to increase. Despite the prevention and optimization of therapy, CHD retains its leadership among all causes of death,
Externí odkaz:
https://doaj.org/article/925a8bc2fe814848afdc332957b986a0
Autor:
Yu. Yu. Kirichenko, I. S. Ilgisonis, T. V. Ivanova, A. S. Zolotukhina, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 7 (2021)
Aim. To study the effect of multiagent chemotherapy on structural and functional vascular, electrophysiological parameters and cardiac hemodynamics in patients with stomach cancer.Material and methods. The study included 3 groups of 25 people: health
Externí odkaz:
https://doaj.org/article/1073d83fb0984a2bb78ff6ca7da72a05
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 1, Pp 73-79 (2013)
One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life
Externí odkaz:
https://doaj.org/article/5d3f4a7ea6bf4cd5bc5db4ffa454fa02
Autor:
Ju. I. Safonova, M. V. Kozhevnikova, Yu. A. Danilogorskaya, E. A. Zheleznykh, I. S. Ilgisonis, E. V. Privalova, N. V. Khabarova, Yu. N. Belenkov
Publikováno v:
Kardiologiia. 62:65-71
Aim To evaluate the effect of perindopril on the endothelial function and levels of endothelial dysfunction markers in groups of patients with heart failure with preserved (HFpEF) and mid-range (intermediate) left ventricular ejection fraction (HFmrE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd61ca35499e8f17bbb68e066c8e986
https://doi.org/10.18087/cardio.2022.1.n1952
https://doi.org/10.18087/cardio.2022.1.n1952
Autor:
E. V. Privalova, G. A. Shakaryants, A. S. Lishuta, N V Khabarova, V. Yu. Kaplunova, D. A. Yatsenko, F. M. Bogatyreva, M V Kozhevnikova, А. V. Emelianov, Yu N Belenkov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 3, Pp 408-413 (2021)
Aim. To study the level of serum biomarkers of endothelial dysfunction and myocardial stress in patients with various types of hypertrophic cardiomyopathy (HCM).Material and Methods. 48 patients with hypertrophic cardiomyopathy (27 men and 21 women)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ab0be5052e4b753713270496c4abf6
https://doi.org/10.20996/1819-6446-2021-06-06
https://doi.org/10.20996/1819-6446-2021-06-06
Publikováno v:
Kardiologiia. 61:52-58
Aim To determine levels of markers for endothelial dysfunction and inflammation, endothelin-1, E-selectin, and tumor necrosis factor α (TNF-α) in patients with ischemic heart disease (IHD) and non-obstructive and obstructive coronary artery (CA) di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b27a3fca5509befa7abcee995b0bc53
https://doi.org/10.18087/cardio.2021.1.n1423
https://doi.org/10.18087/cardio.2021.1.n1423
Autor:
J. I. Safonova, M. V. Kozhevnikova, Yu. A. Danilogorskaya, E. A. Zheleznykh, V. Y. Zektser, A. A. Shchendrygina, I. S. Ilgisonis, E. V. P., N. V. Khabarova, Yu. N. Belenkov
Publikováno v:
Kardiologiia. 60:65-70
Aim To evaluate the effect of 12-month perindopril treatment on structure and function of microvasculature (MV) in patients with chronic heart failure with preserved (HFpEF) and intermediate (HFiEF) left ventricular ejection fraction.Material and met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d9287d4c84fd71a0fe96eab91a0018
https://doi.org/10.18087/cardio.2020.8.n1216
https://doi.org/10.18087/cardio.2020.8.n1216
Autor:
Yu N Belenkov, Yu Yu Kirichenko, D. A. Budanova, N V Khabarova, K. V. Lobastov, G. A. Shakaryants
Publikováno v:
Kardiologiia. 60:71-79
Oncological patients are a high-risk group for venous thromboembolic complications. These complications significantly impair the outcome of antitumor treatment and take a leading place in the structure of mortality. Treatment of venous thromboembolic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a5273747d652a213bd3c80511dd3f0
https://doi.org/10.18087/cardio.2020.3.n904
https://doi.org/10.18087/cardio.2020.3.n904